Chuah YK, Basir R, Talib H, et al. Receptor for advanced glycation end products and its involvement in inflammatory diseases. Int J Inflam 2013;2013:403460.

Alteri E, Guizzaro L. Be open about drug failures to speed up research. Nature 2018;563:317-319.

Morrone CD, Liu M, Black SE, et al. Interaction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanisms. Front Aging Neurosci 2015;7:64.

Attems J, Jellinger K, Thal DR, et al. Review: sporadic cerebral amyloid angiopathy. Neuropathol Appl Neurobiol 2011;37:75-93.

Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 2012;4:147ra111.

Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature 2015;523:337-341.

Boland B, Yu WH, Corti O, et al. Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing.Nat Rev Drug Discov 2018;17:660-688.

Zeng Q, Siu W, Li L, et al. Autophagy in Alzheimer's disease and promising modulatory effects of herbal medicine. Exp Gerontol 2019;119:100-110.

Jarrell JT, Gao L, Cohen DS, et al. Network medicine for Alzheimer's disease and traditional Chinese medicine. Molecules 2018;23.

Revett TJ, Baker GB, Jhamandas J, et al. Glutamate system,amyloid β peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. J Psychiatry Neurosci 2013;38:6-23.

Cai Z, Liu N, Wang C, et al. Role of RAGE in Alzheimer's disease. Cell Mol Neurobiol 2016;36:483-495.

Liu L, Wan W, Xia S, et al. Dysfunctional Wnt/β-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer's disease. Neurochem Int 2014;75:19-25.

Deane R, Sagare A, Zlokovic BV. The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease. Curr Pharm Des 2008;14:1601-1605.

Deane R, Wu Z, Sagare A, et al. LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.Neuron 2004;43:333-344.

Miller MC, Tavares R, Johanson CE, et al. Hippocampal RAGE immunoreactivity in early and advanced Alzheimer's disease.Brain Res 2008;1230:273-280.

Sharma HS, Castellani RJ, Smith MA, et al. The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery. Int Rev Neurobiol 2012;102:47-90.

Da Mesquita S, Louveau A, Vaccari A, et al. Functional aspects of meningeal lymphatics in ageing and Alzheimer's disease.Nature 2018;560:185-191.

Wang L, Zhang Y, Zhao Y, et al. Deep cervical lymph node ligation aggravates AD-like pathology of APP/PS1 mice. Brain Pathol 2019;29:176-192.

Xu Z, Xiao N, Chen Y, et al. Deletion of aquaporin-4 in APP/PS1 mice exacerbates brain Aβ accumulation and memory deficits. Mol Neurodegener 2015;10:58.

Smith AJ, Duan T, Verkman AS. Aquaporin-4 reduces neuropathology in a mouse model of Alzheimer's disease by remodeling peri-plaque astrocyte structure. Acta Neuropathol Commun 2019;7:74.

Gao X, Ming J, Liu S, et al. Sevoflurane enhanced the clearance of Aβ1-40 in hippocampus under surgery via up-regulating AQP-4 expression in astrocyte. Life Sci 2019;221:143-151.

Moftakhar P, Lynch MD, Pomakian JL, et al. Aquaporin expression in the brains of patients with or without cerebral amyloid angiopathy. J Neuropathol Exp Neurol 2010;69:1201-1209.

Yang J, Lunde LK, Nuntagij P, et al. Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer's disease. J Alzheimers Dis 2011;27:711-722.

Zhang J, Zhan Z, Li X, et al. Intermittent fasting protects against Alzheimer's disease possible through restoring aquaporin-4 polarity. Front Mol Neurosci 2017;10:395.

Yin M, Pu T, Wang L, et al. Astroglial water channel aquaporin 4-mediated glymphatic clearance function: a determined factor for time-sensitive treatment of aerobic exercise in patients with Alzheimer's disease. Med Hypotheses 2018;119:18-21.

Noell S, Wolburg-Buchholz K, Mack AF, et al. Evidence for a role of dystroglycan regulating the membrane architecture of astroglial endfeet. Eur J Neurosci 2011;33:2179-2186.

Noell S, Fallier-Becker P, Deutsch U, et al. Agrin defines polarized distribution of orthogonal arrays of particles in astrocytes. Cell Tissue Res 2009;337:185-195.

Amiry-Moghaddam M, Frydenlund DS, Ottersen OP. Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport.Neuroscience 2004;129:999-1010.

Neely JD, Amiry-Moghaddam M, Ottersen OP, et al. Syntrophin-dependent expression and localization of aquaporin-4 water channel protein. Proc Natl Acad Sci USA 2001;98:14108-14113.

Qiu GP, Xu J, Zhuo F, et al. Loss of AQP4 polarized localization with loss of β-dystroglycan immunoreactivity may induce brain edema following intracerebral hemorrhage. Neurosci Lett 2015;588:42-48.

Zhao XL, Li GZ, Sun B, et al. MMP-mediated cleavage of beta-dystroglycan in myelin sheath is involved in autoimmune neuritis.Biochem Biophys Res Commun 2010;392:551-556.

Yan W, Zhao X, Chen H, et al. β-Dystroglycan cleavage by matrix metalloproteinase-2/-9 disturbs aquaporin-4 polarization and influences brain edema in acute cerebral ischemia.Neuroscience 2016;326:141-157.

Bruno MA, Mufson EJ, Wuu J, et al. Increased matrix metalloproteinase 9 activity in mild cognitive impairment. J Neuropathol Exp Neurol 2009;68:1309-1318.

Lorenzl S, Albers DS, Relkin N, et al. Increased plasma levels of matrix metalloproteinase-9 in patients with Alzheimer's disease. Neurochem Int 2003;43:191-196.

Montagne A, Nation DA, Sagare AP, et al. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.Nature 2020;581:71-76.

Yang W, Wu Q, Yuan C, et al. Aquaporin-4 mediates astrocyte response to β-amyloid. Mol Cell Neurosci 2012;49:406-414.

Csernansky JG, Dong H, Fagan AM, et al. Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia. Am J Psychiatry 2006;163:2164-2169.

Popp J, Wolfsgruber S, Heuser I, et al. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type. Neurobiol Aging 2015;36:601-607.

Green KN, Billings LM, Roozendaal B, et al. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J Neurosci 2006;26:9047-9056.

Baglietto-Vargas D, Medeiros R, Martinez-Coria H, et al.Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology. Biol Psychiatry 2013;74:357-366.

Wei F, Song J, Zhang C, et al. Chronic stress impairs the aquaporin-4-mediated glymphatic transport through glucocorticoid signaling. Psychopharmacology (Berl) 2019;236:1367-1384.

Breslin JW. Mechanical forces and lymphatic transport.Microvasc Res 2014;96:46-54.

Antila S, Karaman S, Nurmi H, et al. Development and plasticity of meningeal lymphatic vessels. J Exp Med 2017;214:3645-3667.

Cha YR, Fujita M, Butler M, et al. Chemokine signaling directs trunk lymphatic network formation along the preexisting blood vasculature. Dev Cell 2012;22:824-836.

Jha SK, Rauniyar K, Karpanen T, et al. Efficient activation of the lymphangiogenic growth factor VEGF-C requires the C-terminal domain of VEGF-C and the N-terminal domain of CCBE1. Sci Rep 2017;7:4916.

Louveau A, Herz J, Alme MN, et al. CNS lymphatic drainage and neuroinflammation are regulated by meningeal lymphatic vasculature. Nat Neurosci 2018;21:1380-1391.

Nurmi H, Saharinen P, Zarkada G, et al. VEGF-C is required for intestinal lymphatic vessel maintenance and lipid absorption.EMBO Mol Med 2015;7:1418-1425.

Tutunea-Fatan E, Majumder M, Xin X, et al. The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis. Mol Cancer 2015;14:35.

Yongjun Y, Shuyun H, Lei C, et al. Atorvastatin suppresses glioma invasion and migration by reducing microglial MT1-MMP expression. J Neuroimmunol 2013;260:1-8.

Langenfurth A, Rinnenthal JL, Vinnakota K, et al. Membrane-type 1 metalloproteinase is upregulated in microglia/brain macrophages in neurodegenerative and neuroinflammatory diseases. J Neurosci Res 2014;92:275-286.

Wong HL, Jin G, Cao R, et al. MT1-MMP sheds LYVE-1 on lymphatic endothelial cells and suppresses VEGF-C production to inhibit lymphangiogenesis. Nat Commun 2016;7:10824.

Zhang Y, Lin C, Zhang L, et al. Cognitive improvement during treatment for mild Alzheimer's disease with a Chinese herbal formula: a randomized controlled trial. PLoS One 2015;10:e0130353.

Furukawa K, Tomita N, Uematsu D, et al. Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease. Geriatr Gerontol Int 2017;17:211-218.

Yang Y, Liu JP, Fang JY, et al. Effect and safety of Huannao Yicong Formula in patients with mild-to-moderate Alzheimer's disease: a randomized, double-blinded, donepezil-controlled trial.Chin J Integr Med 2019;25:574-581.

Liu P, Kong M, Liu S, et al. Effect of reinforcing kidney-essence,removing phlegm, and promoting mental therapy on treating Alzheimer's disease. J Tradit Chin Med 2013;33:449-454.

Feng CZ, Cao L, Luo D, et al. Dendrobium polysaccharides attenuate cognitive impairment in senescence-accelerated mouse prone 8 mice via modulation of microglial activation. Brain Res 2019;1704:1-10.

Huang Y, Guo B, Shi B, et al. Chinese herbal medicine Xueshuantong enhances cerebral blood flow and improves neural functions in Alzheimer's disease mice. J Alzheimers Dis 2018;63:1089-1107.

Zhang Z, Wang X, Zhang D, et al. Geniposide-mediated protection against amyloid deposition and behavioral impairment correlates with downregulation of mTOR signaling and enhanced autophagy in a mouse model of Alzheimer's disease. Aging(Albany NY) 2019;11:536-548.

Kawakami Z, Ikarashi Y, Kase Y. Glycyrrhizin and its metabolite 18 beta-glycyrrhetinic acid in glycyrrhiza, a constituent herb of yokukansan, ameliorate thiamine deficiency-induced dysfunction of glutamate transport in cultured rat cortical astrocytes. Eur J Pharmacol 2010;626:154-158.

Zhu SM, Xiong XX, Zheng YY, et al. Propofol inhibits aquaporin 4 expression through a protein kinase C-dependent pathway in an astrocyte model of cerebral ischemia/reoxygenation. Anesth Analg 2009;109:1493-1499.

Ko HM, Joo SH, Kim P, et al. Effects of Korean Red Ginseng extract on tissue plasminogen activator and plasminogen activator inhibitor-1 expression in cultured rat primary astrocytes. J Ginseng Res 2013;37:401-412.

Chu H, Ding H, Tang Y, et al. Erythropoietin protects against hemorrhagic blood-brain barrier disruption through the effects of aquaporin-4. Lab Invest 2014;94:1042-1053.

Qi LL, Fang SH, Shi WZ, et al. CysLT2 receptor-mediated AQP4 up-regulation is involved in ischemic-like injury through activation of ERK and p38 MAPK in rat astrocytes. Life Sci 2011;88:50-56.

Kaufmann D, Kaur Dogra A, Tahrani A, et al. Extracts from traditional Chinese medicinal plants inhibit acetylcholinesterase, a known Alzheimer's disease target. Molecules 2016;21:1161.

Li Y, Wang B, Liu C, et al. Inhibiting c-Jun N-terminal kinase(JNK)-mediated apoptotic signaling pathway in PC12 cells by a polysaccharide (CCP) from Coptis chinensis against amyloid-β(Aβ)-induced neurotoxicity. Int J Biol Macromol 2019;134:565-574.

Li J, Ni L, Li B, et al. Coptis Chinensis affects the function of glioma cells through the down-regulation of phosphorylation of STAT3 by reducing HDAC3. BMC Complement Altern Med 2017;17:524.

Zhao C, Zhang H, Li H, et al. Geniposide ameliorates cognitive deficits by attenuating the cholinergic defect and amyloidosis in middle-aged Alzheimer model mice. Neuropharmacology 2017;116:18-29.

Gao C, Liu Y, Jiang Y, et al. Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced Alzheimer rat model. Brain Pathol 2014;24:261-269.

Li C, Wang X, Cheng F, et al. Geniposide protects against hypoxia/reperfusion-induced blood-brain barrier impairment by increasing tight junction protein expression and decreasing inflammation, oxidative stress, and apoptosis in an in vitro system. Eur J Pharmacol 2019;854:224-231.

Liu C, Chen K, Lu Y, et al. Catalpol provides a protective effect on fibrillary Aβ1-42-induced barrier disruption in an in vitro model of the blood-brain barrier. Phytother Res 2018;32:1047-1055.

Yang CM, Yang SH, Lee TH, et al. Evaluation of anti-inflammatory effects of Helminthostachys zeylanica extracts via inhibiting bradykinin-induced MMP-9 expression in brain astrocytes. Mol Neurobiol 2016;53:5995-6005.

Hu Q, Yu B, Chen Q, et al. Effect of Linguizhugan Decoction on neuroinflammation and expression disorder of the amyloid β-related transporters RAGE and LRP-1 in a rat model of Alzheimer's disease. Mol Med Rep 2018;17:827-834.

Yang P, Chen A, Qin Y, et al. Buyang Huanwu Decoction combined with BMSCs transplantation promotes recovery after spinal cord injury by rescuing axotomized red nucleus neurons.J Ethnopharmacol 2019;228:123-131.

Liu B, Liu G, Wang Y, et al. Protective effect of Buyang Huanwu Decoction on neurovascular unit in Alzheimer's disease cell model via inflammation and RAGE/LRP1 pathway. Med Sci Monit 2019;25:7813-7825.

Jayasingh Chellammal HS, Veerachamy A, Ramachandran D,et al. Neuroprotective effects of 1`δ-1`-acetoxyeugenol acetate on Aβ(25-35) induced cognitive dysfunction in mice. Biomed Pharmacother 2019;109:1454-1461.

Zhou YQ, Yang ZL, Xu L, et al. Akebia saponin D, a saponin component from Dipsacus asper Wall, protects PC 12 cells against amyloid-beta induced cytotoxicity. Cell Biol Int 2009;33:1102-1110.

Wang Y, Shen J, Yang X, et al. Akebia saponin D reverses corticosterone hypersecretion in an Alzheimer's disease rat model. Biomed Pharmacother 2018;107:219-225.

Leung KW, Ng HM, Tang MK, et al. Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesis. Angiogenesis 2011;14:515-522.

Yu J, Mao L, Guan L, et al. Ginsenoside Rg1 enhances lymphatic transport of intrapulmonary silica via VEGF-C/VEGFR-3 signaling in silicotic rats. Biochem Biophys Res Commun 2016;472:182-188.

Jia F, Mou L, Ge H. Protective effects of ginsenoside Rb1 on H2O2-induced oxidative injury in human endothelial cell line (EA.hy926) via miR-210. Int J Immunopathol Pharmacol 2019;33:2058738419866021.

Meng ZY, Kang HL, Duan W, et al. MicroRNA-210 promotes accumulation of neural precursor cells around ischemic foci after cerebral ischemia by regulating the SOCS1-STAT3-VEGF-C pathway. J Am Heart Assoc 2018;7:e005052.

Li J, Chen Y, Zhang L, et al. Total saponins of panaxnotoginseng promotes lymphangiogenesis by activation VEGF-C expression of lymphatic endothelial cells. J Ethnopharmacol 2016;193:293-302.

Yang XN, Li CS, Chen C, et al. Protective effect of Shouwu Yizhi Decoction against vascular dementia by promoting angiogenesis. Chin J Nat Med 2017;15:740-750.

Duan MH, Wang LN, Jiang YH, et al. Angelica sinensis reduced Aβ-induced memory impairment in rats. J Drug Target 2016;24:340-347.

Piltonen M, Planken A, Leskelä O, et al. Vascular endothelial growth factor C acts as a neurotrophic factor for dopamine neurons in vitro and in vivo. Neuroscience 2011;192:550-563.

Luo L, Kim SW, Lee HK, et al. Anti-Zn2+-toxicity of 4-hydroxybenzyl alcohol in astrocytes and neurons contribute to a robust neuroprotective effects in the postischemic brain. Cell Mol Neurobiol 2018;38:615-626.

Chen WC, Lai YS, Lin SH, et al. Anti-depressant effects of Gastrodia elata Blume and its compounds gastrodin and 4-hydroxybenzyl alcohol, via the monoaminergic system and neuronal cytoskeletal remodeling. J Ethnopharmacol 2016;182:190-199.

Kim BW, Koppula S, Kim JW, et al. Modulation of LPS-stimulated neuroinflammation in BV-2 microglia by Gastrodia elata: 4-hydroxybenzyl alcohol is the bioactive candidate. J Ethnopharmacol 2012;139:549-557.

Luo L, Kim SW, Lee HK, et al. Anti-oxidative effects of 4-hydroxybenzyl alcohol in astrocytes confer protective effects in autocrine and paracrine manners. PLoS One 2017;12:e0177322.

Zhang X, Fei X, Tao W, et al. Neuroprotective effect of Modified Xijiao Dihuang Decoction against oxygen-glucose deprivation and reoxygenation-induced injury in PC12 cells: involvement of TLR4-MyD88/NF-κB signaling pathway. Evid Based Complement Alternat Med 2017;2017:3848595.

Fei X, Zhang X, Wang Q, et al. Xijiao Dihuang Decoction alleviates ischemic brain injury in MCAO rats by regulating inflammation, neurogenesis, and angiogenesis. Evid Based Complement Alternat Med 2018;2018:5945128.

Wan J, Wan H, Yang R, et al. Protective effect of Danhong Injection combined with Naoxintong Capsule on cerebral ischemia-reperfusion injury in rats. J Ethnopharmacol 2018;211:348-357.

Pang MF, Georgoudaki AM, Lambut L, et al. TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis. Oncogene 2016;35:748-760.

Yang Z, Zhao T, Zou Y, et al. Curcumin inhibits microglia inflammation and confers neuroprotection in intracerebral hemorrhage. Immunol Lett 2014;160:89-95.

Lu L, Li HQ, Li JH, et al. Neuroprotection of Sanhua Decoction against focal cerebral ischemia/reperfusion injury in rats through a mechanism targeting aquaporin 4. Evid Based Complement Alternat Med 2015;2015:584245.

Cheng CY, Ho TY, Hsiang CY, et al. Angelica sinensis exerts angiogenic and anti-apoptotic effects against cerebral ischemia-reperfusion injury by activating p38MAPK/HIF-1/VEGF-A signaling in rats. Am J Chin Med 2017;45:1683-1708.

Zhang M, Cui Z, Cui H, et al. Astaxanthin alleviates cerebral edema by modulating NKCC1 and AQP4 expression after traumatic brain injury in mice. BMC Neurosci 2016;17:60.